What is Aclaris Therapeutics's free cash flow margin?

Aclaris Therapeutics (ACRS) reported free cash flow margin of -624.9% in Q1 2026.

What is the long-term trend for Aclaris Therapeutics's free cash flow margin?

Over 3 years (2020 to 2025), Aclaris Therapeutics's free cash flow margin has grown at a 0.0% compound annual growth rate (CAGR), from -603% to -603.4%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Aclaris Therapeutics ACRS Free cash flow margin

Free cash flow margin at other companies

IncyteINCY

28.2%+19.7pp

Avalo TherapeuticsAVTX

-11,123.8%-13,374pp

Shattuck Labs, Inc.STTK

-4,140.8%-7,144pp

Kymera TherapeuticsKYMR

-474%+92.4pp

CytomX TherapeuticsCTMX

-225.6%-334pp

AnaptysBio, Inc.ANAB

1.9%+1.0pp

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Calculated from Aclaris Therapeutics’s reported figures.

free cash flow/total revenue=-624.9%

Based on trailing twelve months.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's free cash flow margin?: Aclaris Therapeutics (ACRS) reported free cash flow margin of -624.9% in Q1 2026.
What is the long-term trend for Aclaris Therapeutics's free cash flow margin?: Over 3 years (2020 to 2025), Aclaris Therapeutics's free cash flow margin has grown at a 0.0% compound annual growth rate (CAGR), from -603% to -603.4%.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.